

Showing 421 - 440 of 1673 results

ANSTO contributes to new understanding of how COVID infects humans
ANSTO’s National Deuteration Facility has provided deuterated cholesterol for international research to gain a better understanding of how the Spike protein of the COVID virus, SARS-Co-V-2, infects human cells through a membrane fusion mechanism.

Deuterated ionic liquids
ANSTO Innovation Precinct briefing for NSW Parliament
ANSTO shared plans for an Innovation Precinct in southern Sydney at a breakfast event.
'Jekyll and Hyde' protein linked to type 1 diabetes

What we do
ANSTO leverages great science to deliver big outcomes. We partner with scientists and engineers and apply new technologies to provide real-world benefits. Our work improves human health, saves lives, builds our industries and protects the environment.

Understanding disease - Causation and progression
This program uses ANSTO’s nuclear capabilities to identify, quantify, and monitor the mechanisms which cause, or influence the development and progression of chronic diseases.
ANSTO facilities and expertise supply a large range of radioisotopes for radiopharmaceutical and environmental applications
Excellent radiolabelling facilities and the operation of OPAL, a world-class multi-purpose nuclear reactor, enable ANSTO to produce a large range of radioisotopes for Australian researchers in both radiopharmaceutical and environmental areas.
Anti leukaemia drug recognised with PM Prize for Innovation
The Australian Synchrotron has played a crucial role in the discovery of a new cancer drug for the treatment of leukaemia.

How safe is OPAL?
The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.
Scholarship applications open
Applications are now being accepted for the Industry foundations Scholarship.

User Meeting 2020 Invited Speakers
The User Advisory Committee (UAC) are pleased to present this year's invited speakers.
Progress on low energy electronics
Soft X-ray experiments used to characterise new thin film topological Dirac Semimetal.

OPAL multi-purpose reactor
Australia’s Open Pool Australian Lightwater (OPAL) reactor is a state-of-the-art 20 megawatt multi-purpose reactor that uses low enriched uranium (LEU) fuel to achieve a range of activities to benefit human health, enable research to support a more sustainable environment and provide innovative solutions for industry.
Miriad profile - nandin member
Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.
Women's fertility linked to detox element selenium in diet

Understanding the full impact of radiation on astronauts
In space, without the protection of the magnetosphere, the type and dose of radiation is considerably different to what is naturally experienced on earth. However, it is the secondary particles of lower energies created when galactic and cosmic radiation interacts with shielding that is of concern for astronauts.

Understanding the full impact of radiation on astronauts
In collaboration with the French National Institute of Health and Medical Research (INSERM) and the French International Space Agency (CNES), ANSTO scientists are undertaking research on the radiobiological effects of secondary particles that are created when radiation interacts with the shielding on the International Space Station.
New advanced material shows extraordinary stability over wide temperature range
Researchers from UNSW have found an extraordinary material that does expand or contract over an extremely wide temperature range and may be one of the most stable materials known.

PhD Scholarship - Innovation, Design and Technology
Three-year full-time PhD program is in partnership between the nandin Innovation Centre (ANSTO) and Design Factory Melbourne (Swinburne University). The PhD is based at ANSTO, Lucas Heights, Sydney, NSW.